Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-02-17FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Solco Healthcare LLC)
FDA approved a supplemental application for the generic fixed-dose combination of telmisartan and hydrochlorothiazide from Solco Healthcare …
-
EMA approval · 2026-02-06EMA Authorised: Dafiro HCT (valsartan;hydrochlorothiazide;amlodipine besilate) — Novartis Europharm Limited
The EMA has authorised Dafiro HCT, a fixed-dose combination of valsartan, hydrochlorothiazide and amlodipine besilate, for the treatment of …
-
EMA approval · 2026-02-06EMA Authorised: Exforge HCT (valsartan;hydrochlorothiazide;amlodipine besilate) — Novartis Europharm Limited
The EMA authorised Exforge HCT, a fixed-dose combination of valsartan, hydrochlorothiazide, and amlodipine besilate, for the treatment of hy…
-
EMA approval · 2026-02-06EMA Authorised: Copalia HCT (amlodipine;valsartan;hydrochlorothiazide) — Novartis Europharm Limited
The European Medicines Agency authorised Copalia HCT, a fixed-dose combination tablet containing amlodipine, valsartan and hydrochlorothiazi…
-
FDA approval · 2026-01-21FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's generic fixed-dose combination of bisoprolol fumarate and hydrochlorothiazide (ANDA 217922). The…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2026-01-20FDA Approved: SACUBITRIL AND VALSARTAN — Original Application (Somerset Therapeutics, LLC)
The FDA approved Somerset Therapeutics' original ANDA for a generic sacubitril/valsartan product, enabling a non-brand version of this heart…
-
EMA approval · 2026-01-19EMA Authorised: Aprovel (irbesartan) — Sanofi Winthrop Industrie
The EMA has authorised Aprovel (irbesartan) by Sanofi Winthrop Industrie for the treatment of hypertension, with decision dated 15 January 2…
-
FDA approval · 2026-01-18FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Slate Run Pharmaceuticals, LLC)
FDA approved a supplemental application for a generic diltiazem hydrochloride product from Slate Run Pharmaceuticals, LLC under an ANDA.
-
EMA approval · 2026-01-16EMA Authorised: Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop) (irbesartan;hydrochlorothiazide) — sanofi-aventis groupe
EMA authorised Irbesartan Hydrochlorothiazide Zentiva for the treatment of hypertension. The product was previously marketed as Irbesartan/H…
-
EMA approval · 2026-01-16EMA Authorised: Karvea (irbesartan) — Sanofi Winthrop Industrie
The European Medicines Agency authorised Karvea (irbesartan) for the treatment of hypertension, with Sanofi Winthrop Industrie as the market…
-
EMA approval · 2026-01-16EMA Authorised: Ifirmacombi (irbesartan;hydrochlorothiazide) — Krka, d.d., Novo mesto
EMA authorised Ifirmacombi, a fixed-dose combination of irbesartan and hydrochlorothiazide for hypertension, with Krka as the marketing auth…
-
EMA approval · 2026-01-16EMA Authorised: Irbesartan/Hydrochlorothiazide Teva (irbesartan;hydrochlorothiazide) — Teva B.V.
The European Medicines Agency authorised a fixed-dose combination of irbesartan and hydrochlorothiazide (Irbesartan/Hydrochlorothiazide Teva…
-
FDA approval · 2026-01-14FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for Irbesartan and Hydrochlorothiazide by Alembic Pharmaceuticals Limited, a generic combination pro…
-
FDA approval · 2026-01-13FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA granted approval of a supplemental application for Benazepril Hydrochloride from Aurobindo Pharma Limited (ANDA 078212).
-
FDA approval · 2026-01-08FDA Approved: FUROSEMIDE — Original Application (Micro Labs Limited)
FDA approved the original application for furosemide from Micro Labs Limited.
-
FDA approval · 2026-01-07FDA Approved: METOLAZONE — Supplemental Application (Method Pharmaceuticals, LLC)
The FDA approved a supplemental application for METOLAZONE submitted by Method Pharmaceuticals, LLC.
-
EMA approval · 2026-01-06EMA Authorised: Talmanco (previously Tadalafil Generics) (tadalafil) — Viatris Limited
Talmanco has been authorised in the EU as a generic tadalafil product with indications in hypertension and pulmonary arterial hypertension, …
-
FDA approval · 2025-12-22FDA Approved: FUROSCIX — Supplemental Application (scPharmaceuticals Inc.)
The FDA approved a supplemental application for FUROSCIX (furosemide injection 80 mg/10 mL) from scPharmaceuticals Inc.
-
FDA approval · 2025-12-18FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (Chengdu Shuode Pharmaceutical Co., Ltd)
FDA approved a supplemental application for nicardipine hydrochloride by Chengdu Shuode Pharmaceutical Co., Ltd, indicating approval of a su…
-
FDA approval · 2025-12-16FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for a generic Losartan Potassium and Hydrochlorothiazide product from Alembic Pharmaceuticals Limite…
-
FDA approval · 2025-12-16FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's supplemental application for losartan potassium (generic).
-
FDA approval · 2025-12-16FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for Camber Pharmaceuticals' Losartan Potassium (generic Losartan Potassium). The approval authorizes…
-
FDA approval · 2025-12-04FDA Approved: EPLERENONE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma Holdings, Inc.'s supplemental application for eplerenone (ANDA 214663), authorizing changes to the approved gener…
-
FDA approval · 2025-11-28FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for IRBESARTAN AND HYDROCHLOROTHIAZIDE from Hikma Pharmaceuticals USA Inc., approving changes under …
-
FDA approval · 2025-11-28FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for the generic combination product irbesartan and hydrochlorothiazide from Aurobindo Pharma Limited…